OpenVSafe by OpenVAERS
Search V-safe

2XM-12037-73291

4 vaccinations 4 coded responses 29 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
370 / TN
Registered
2021-08-28
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-03
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-26
    Dose 2 — Pfizer-BioNTech
  3. 2021-08-28
    Registered in v-safe
  4. 2021-08-28
    Dose 3 — Pfizer-BioNTech
  5. 2021-08-28
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  6. 2021-08-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  7. 2021-08-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Itching · Headache
    Adult check-in
  8. 2021-08-31
    Survey response — days 1–6 daily, dose 3
    MedDRA: Blood glucose decreased — Feeling: Fair · Nausea, Abdominal pain
    Free text: Blood sugar dropped
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  9. 2021-09-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Nausea, Vomiting · Be unable to do your normal daily activities
    Adult check-in
  10. 2021-09-06
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  11. 2021-09-11
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  12. 2021-09-18
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  13. 2021-09-25
    Survey response — day 28, dose 3
    MedDRA: Headache — Feeling: Good
    Free text: Headache pain
    MedDRA releases: 2024-11 · check-in free text available
  14. 2021-10-04
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  15. 2021-10-09
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  16. 2021-11-27
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-02-26
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  18. 2022-02-28
    Dose 4 — Pfizer-BioNTech
  19. 2022-02-28
    Survey response — day 0, dose 4
    MedDRA: Injection site pain — Feeling: Fair
    Free text: Burning periodically at injection site
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-03-01
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  21. 2022-03-02
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  22. 2022-03-03
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Chills · Be unable to do your normal daily activities
    Adult check-in
  23. 2022-03-04
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  24. 2022-03-05
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  25. 2022-03-06
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  26. 2022-03-07
    Health check-in — day 7, dose 4
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  27. 2022-03-14
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  28. 2022-03-21
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  29. 2022-03-28
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  30. 2022-04-04
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  31. 2022-04-11
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  32. 2022-05-30
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  33. 2022-08-29
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in
  34. 2023-02-28
    Survey response — 12 months, dose 4
    MedDRA: Dyspnoea, Headache, Weight increased — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  35. 2023-02-28
    Report sent to call center — 12 months, dose 4
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  36. 2023-03-01
  37. 2023-03-02
  38. 2023-03-02

Vaccinations

DoseDateManufacturerCo-administered
12021-02-03Pfizer-BioNTech No
22021-02-26Pfizer-BioNTech No
32021-08-28Pfizer-BioNTech No
42022-02-28Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2023-02-28 Unsuccessful

Free text

Release 9 — days 1–6 daily, dose 3

2021-08-31

Systemic reaction (other): Blood sugar dropped

Release 9 — day 28, dose 3

2021-09-25

Symptoms: Headache pain

Release 11 — day 0, dose 4

2022-02-28

Systemic reaction (other): Burning periodically at injection site

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDyspnoea · · ✓
SDHeadache · · ✓
SDWeight increased · · ✓
SROBlood glucose decreased ✓ · ✓
SROInjection site pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…